Guangdong Biolight Meditech Co., Ltd. (300246.SZ)
CNY 7.6
(-0.78%)
CNY 7.6
(-0.78%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 220.37 Million CNY | 9.87% |
| 2022 | 200.57 Million CNY | 3.65% |
| 2021 | 193.5 Million CNY | 30.58% |
| 2020 | 148.18 Million CNY | 79.69% |
| 2019 | 82.46 Million CNY | -16.72% |
| 2018 | 99.01 Million CNY | 10.41% |
| 2017 | 89.68 Million CNY | 28.47% |
| 2016 | 69.8 Million CNY | 17.31% |
| 2015 | 59.5 Million CNY | 11.37% |
| 2014 | 53.43 Million CNY | 12.66% |
| 2013 | 47.43 Million CNY | 32.68% |
| 2012 | 35.74 Million CNY | 16.24% |
| 2011 | 30.75 Million CNY | 17.9% |
| 2010 | 26.08 Million CNY | 48.99% |
| 2009 | 17.5 Million CNY | -1.33% |
| 2008 | 17.74 Million CNY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 212.46 Million CNY | -1.88% |
| 2024 Q3 | 227.38 Million CNY | 7.02% |
| 2024 Q1 | 216.54 Million CNY | -1.74% |
| 2023 Q3 | 223.69 Million CNY | -2.61% |
| 2023 FY | 220.37 Million CNY | 9.87% |
| 2023 Q2 | 229.68 Million CNY | -25.05% |
| 2023 Q4 | 220.37 Million CNY | -1.48% |
| 2023 Q1 | 306.43 Million CNY | 52.78% |
| 2022 Q3 | 210.36 Million CNY | 3.12% |
| 2022 Q2 | 204 Million CNY | 15.81% |
| 2022 Q1 | 176.14 Million CNY | -8.97% |
| 2022 FY | 200.57 Million CNY | 3.65% |
| 2022 Q4 | 200.57 Million CNY | -4.66% |
| 2021 Q1 | 150.16 Million CNY | 1.34% |
| 2021 FY | 193.5 Million CNY | 30.58% |
| 2021 Q4 | 193.5 Million CNY | 5.5% |
| 2021 Q3 | 183.41 Million CNY | 19.45% |
| 2021 Q2 | 153.55 Million CNY | 2.25% |
| 2020 Q1 | 100.5 Million CNY | 21.88% |
| 2020 Q3 | 154.49 Million CNY | -1.33% |
| 2020 Q4 | 148.18 Million CNY | -4.09% |
| 2020 FY | 148.18 Million CNY | 79.69% |
| 2020 Q2 | 156.57 Million CNY | 55.79% |
| 2019 Q1 | 98.88 Million CNY | -0.13% |
| 2019 FY | 82.46 Million CNY | -16.72% |
| 2019 Q4 | 82.46 Million CNY | -10.1% |
| 2019 Q3 | 91.72 Million CNY | -10.16% |
| 2019 Q2 | 102.09 Million CNY | 3.24% |
| 2018 Q3 | 108.2 Million CNY | 15.97% |
| 2018 Q4 | 99.01 Million CNY | -8.49% |
| 2018 Q2 | 93.29 Million CNY | -5.17% |
| 2018 FY | 99.01 Million CNY | 10.41% |
| 2018 Q1 | 98.38 Million CNY | 9.7% |
| 2017 Q4 | 89.68 Million CNY | 7.65% |
| 2017 Q3 | 83.3 Million CNY | 1.11% |
| 2017 Q2 | 82.39 Million CNY | 5.81% |
| 2017 Q1 | 77.86 Million CNY | 11.55% |
| 2017 FY | 89.68 Million CNY | 28.47% |
| 2016 Q1 | 65.33 Million CNY | 9.8% |
| 2016 FY | 69.8 Million CNY | 17.31% |
| 2016 Q4 | 69.8 Million CNY | -9.17% |
| 2016 Q3 | 76.86 Million CNY | 12.11% |
| 2016 Q2 | 68.56 Million CNY | 4.93% |
| 2015 Q3 | 61.92 Million CNY | 1.31% |
| 2015 Q2 | 61.12 Million CNY | 8.03% |
| 2015 Q1 | 56.57 Million CNY | 5.89% |
| 2015 FY | 59.5 Million CNY | 11.37% |
| 2015 Q4 | 59.5 Million CNY | -3.9% |
| 2014 Q1 | 49.55 Million CNY | 4.49% |
| 2014 Q2 | 50.78 Million CNY | 2.48% |
| 2014 FY | 53.43 Million CNY | 12.66% |
| 2014 Q4 | 53.43 Million CNY | 3.65% |
| 2014 Q3 | 51.55 Million CNY | 1.5% |
| 2013 Q4 | 47.43 Million CNY | -11.84% |
| 2013 FY | 47.43 Million CNY | 32.68% |
| 2013 Q3 | 53.79 Million CNY | 16.63% |
| 2013 Q2 | 46.12 Million CNY | 17.96% |
| 2013 Q1 | 39.1 Million CNY | 9.39% |
| 2012 Q1 | 36.77 Million CNY | 19.6% |
| 2012 Q3 | 44.33 Million CNY | 5.28% |
| 2012 Q4 | 35.74 Million CNY | -19.38% |
| 2012 FY | 35.74 Million CNY | 16.24% |
| 2012 Q2 | 42.11 Million CNY | 14.51% |
| 2011 Q3 | 34.32 Million CNY | 11.7% |
| 2011 Q2 | 30.73 Million CNY | 0.0% |
| 2011 FY | 30.75 Million CNY | 17.9% |
| 2011 Q4 | 30.75 Million CNY | -10.41% |
| 2010 FY | 26.08 Million CNY | 48.99% |
| 2010 Q4 | 26.08 Million CNY | 0.0% |
| 2009 FY | 17.5 Million CNY | -1.33% |
| 2008 FY | 17.74 Million CNY | 0.0% |